It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

BACE1 Inhibitor Treatment Study in Individuals with Mild to Moderate Alzheimer’s Disease

Clinical Trial Title: 
BACE1 Inhibitor Treatment Study in Individuals with Mild to Moderate Alzheimer’s Disease
Clinical Trial Protocol ID: 
11120605
Clinical Trial Investigator Name: 
Raj C. Shah, MD
Clinical Trial Protocol Description: 

The purpose of this 20-month trial is to evaluate the safety and effectiveness of multiple doses of an experimental drug compared to placebo when given to people with Alzheimer’s disease. At Rush University Medical Center, we anticipate recruiting approximately 18 people. Treatment or matching placebo will be assigned randomly.

Clinical Trial Eligibility Criteria: 

In order to participate you must have:

  • Are 55 to 85 years of age
  • Have been diagnosed with Alzheimer’s disease
  • Have a study partner willing to accompany you to all study visits

You will be excluded from the study if  you:

  • Are unwilling or unable to undergo multiple MRI scans
  • Have medical conditions that are not stable or that require adjustments of your medications

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Alzheimer’s Disease and Related Dementias
Contact Phone: 
(312) 942-3033
Contact Name: 
Pat Samuels